Form D — IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P.
0002071562-26-000003 · filed Jul 21, 2026
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06c, 3C, 3C.7
- Total offering
- —
- Total sold
- $26,450,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P.
- CIK
- 2071562
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- C/O COMPLIANCE DEPARTMENT
NEW YORK, NY 10165 - Phone
- 2129947400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
- iCapital PE GP, LLC · PromoterNew York, NY Find on LinkedIn ↗
-
Lauren Unger · Executive OfficerNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗